Advertisement
U.S. Markets open in 5 hrs 46 mins
S&P Futures
5,953.25 +14.50 (+0.24%) Dow Futures
43,524.00 +124.00 (+0.29%) Nasdaq Futures
20,817.50 +49.75 (+0.24%) Russell 2000 Futures
2,339.40 +5.30 (+0.23%) Crude Oil
69.72 +0.33 (+0.48%) Gold
2,625.20 -5.80 (-0.22%)
Vivos Therapeutics, Inc. (VVOS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 2.7100 |
| Open | 2.6300 |
| Bid | 2.0300 x 200 |
| Ask | 3.2300 x 200 |
| Day's Range | 2.5100 - 2.8600 |
| 52 Week Range | 1.9100 - 48.7900 |
| Volume | |
| Avg. Volume | 1,392,222 |
| Market Cap | 13.684M |
| Beta (5Y Monthly) | 7.68 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.9900 |
| Earnings Date | Nov 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.30 |
Simply Wall St.Vivos Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Vivos Therapeutics ( NASDAQ:VVOS ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.86m (up 17% from 3Q...
- GuruFocus.com
Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
Vivos Therapeutics Inc (VVOS) reports strong revenue growth and strategic advancements, despite facing increased net losses and market uncertainties.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.